Evidence map›Paper›PMID 27797529›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2016

Evolution of Multivalent Nanoparticle Adhesion via Specific Molecular Interactions.

Mingqiu Wang, Shreyas R Ravindranath, Maha K Rahim, Elliot L Botvinick, Jered B Haun

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingqiu WangDepartment of Biomedical Engineering, ‡Department of Surgery, School of Medicine, §Department of Chemical Engineering and Materials Science, ∥Chao Family Comprehensive Cancer Center, ⊥Beckman Laser Institute, and #Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California-Irvine , Irvine, California 92697, United States.
Shreyas R RavindranathDepartment of Biomedical Engineering, ‡Department of Surgery, School of Medicine, §Department of Chemical Engineering and Materials Science, ∥Chao Family Comprehensive Cancer Center, ⊥Beckman Laser Institute, and #Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California-Irvine , Irvine, California 92697, United States.
Maha K RahimDepartment of Biomedical Engineering, ‡Department of Surgery, School of Medicine, §Department of Chemical Engineering and Materials Science, ∥Chao Family Comprehensive Cancer Center, ⊥Beckman Laser Institute, and #Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California-Irvine , Irvine, California 92697, United States.
Elliot L BotvinickDepartment of Biomedical Engineering, ‡Department of Surgery, School of Medicine, §Department of Chemical Engineering and Materials Science, ∥Chao Family Comprehensive Cancer Center, ⊥Beckman Laser Institute, and #Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California-Irvine , Irvine, California 92697, United States.
Jered B HaunDepartment of Biomedical Engineering, ‡Department of Surgery, School of Medicine, §Department of Chemical Engineering and Materials Science, ∥Chao Family Comprehensive Cancer Center, ⊥Beckman Laser Institute, and #Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California-Irvine , Irvine, California 92697, United States.

Funding

WOUND MIGRATION FORCE MONITORINGP41RR001192 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYUBOVITSKY, JULIA · 1985 to 2011
$14.2M
Virtual Photonocs TechnologiesP41EB015890 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI DURKIN, ANTHONY J · 2012 to 2017
$7.0M
NCRR NIH HHS P41 RR001192NIBIB NIH HHS P41 EB015890
6 · The paper itself

Abstract

The targeted delivery of nanoparticle carriers holds tremendous potential to transform the detection and treatment of diseases. A major attribute of nanoparticles is the ability to form multiple bonds with target cells, which greatly improves the adhesion strength. However, the multivalent binding of nanoparticles is still poorly understood, particularly from a dynamic perspective. In previous experimental work, we studied the kinetics of nanoparticle adhesion and found that the rate of detachment decreased over time. Here, we have applied the adhesive dynamics simulation framework to investigate binding dynamics between an antibody-conjugated, 200-nm-diameter sphere and an ICAM-1-coated surface on the scale of individual bonds. We found that nano adhesive dynamics (NAD) simulations could replicate the time-varying nanoparticle detachment behavior that we observed in experiments. As expected, this behavior correlated with a steady increase in mean bond number with time, but this was attributed to bond accumulation only during the first second that nanoparticles were bound. Longer-term increases in bond number instead were manifested from nanoparticle detachment serving as a selection mechanism to eliminate nanoparticles that had randomly been confined to lower bond valencies. Thus, time-dependent nanoparticle detachment reflects an evolution of the remaining nanoparticle population toward higher overall bond valency. We also found that NAD simulations precisely matched experiments whenever mechanical force loads on bonds were high enough to directly induce rupture. These mechanical forces were in excess of 300 pN and primarily arose from the Brownian motion of the nanoparticle, but we also identified a valency-dependent contribution from bonds pulling on each other. In summary, we have achieved excellent kinetic consistency between NAD simulations and experiments, which has revealed new insights into the dynamics and biophysics of multivalent nanoparticle adhesion. In future work, we will leverage the simulation as a design tool for optimizing targeted nanoparticle agents.

Indexed as

AntibodiesBiophysicsIntercellular Adhesion Molecule-1KineticsNanoparticlesAntibodiesIntercellular Adhesion Molecule-1

Identifiers

PMID27797529
PMCPMC5321555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.